Exponent (NASDAQ:EXPO) CEO Catherine Corrigan Sells 4,900 Shares of Stock

Exponent, Inc. (NASDAQ:EXPO) CEO Catherine Corrigan sold 4,900 shares of Exponent stock in a transaction on Monday, November 17th. The shares were sold at an average price of $70.39, for a total value of $344,911.00. Following the transaction, the chief executive officer owned 83,429 shares of the company’s stock, valued at $5,872,567.31. The trade was a 5.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Catherine Corrigan also recently made the following trade(s):

• On Wednesday, October 15th, Catherine Corrigan sold 4,930 shares of Exponent stock. The shares were sold at an average price of $66.82, for a total value of $329,422.60.
• On Monday, September 15th, Catherine Corrigan sold 4,905 shares of Exponent stock. The stock was sold at an average price of $69.91, for a total value of $342,908.55.

Exponent Price Performance

Shares of Exponent stock opened at $68.76 on Wednesday. Exponent, Inc. has a 1 year low of $63.81 and a 1 year high of $101.37. The firm’s 50-day moving average is $68.95 and its 200 day moving average is $72.31. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of 34.38 and a beta of 0.91.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, October 30th. The business services provider reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.05. The business had revenue of $147.12 million during the quarter, compared to analysts’ expectations of $131.78 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.50 earnings per share. On average, equities analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Friday, December 5th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Friday, December 5th. Exponent’s payout ratio is presently 58.54%.

Exponent declared that its Board of Directors has authorized a share repurchase program on Thursday, October 30th that permits the company to repurchase $100.00 million in shares. This repurchase authorization permits the business services provider to repurchase up to 3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. William Blair upgraded Exponent from a “market perform” rating to an “outperform” rating in a research note on Monday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Institutional Investors Weigh In On Exponent

A number of hedge funds have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. boosted its stake in shares of Exponent by 3.2% in the 1st quarter. Victory Capital Management Inc. now owns 30,376 shares of the business services provider’s stock worth $2,462,000 after buying an additional 931 shares during the last quarter. Allianz Asset Management GmbH purchased a new stake in Exponent during the first quarter valued at $454,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Exponent in the first quarter valued at about $1,306,000. Royce & Associates LP boosted its position in Exponent by 5.0% in the first quarter. Royce & Associates LP now owns 213,179 shares of the business services provider’s stock worth $17,280,000 after purchasing an additional 10,198 shares during the last quarter. Finally, Avantax Advisory Services Inc. boosted its position in Exponent by 6.2% in the first quarter. Avantax Advisory Services Inc. now owns 20,062 shares of the business services provider’s stock worth $1,626,000 after purchasing an additional 1,178 shares during the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.